Flentke GR, Garic A, Hernandez M, Smith SM (2014) CaMKII represses transcriptionally active β-catenin to mediate acute ethanol neurodegeneration and can phosphorylate β-catenin. J Neurochem 128, 523-35 24117889

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

T332-p - CTNNB1 (human) ▲
Modsite: VNIMRTytyEkLLWT SwissProt Entrez-Gene Orthologous residues CTNNB1 (human): T332‑p, CTNNB1 (mouse): T332‑p, CTNNB1 (rat): T332‑p, CTNNB1 (rabbit): T332‑p Characterization Enzymes shown to modify site in vitro:  Type Enzyme KINASE CAMK2A (human) Downstream Regulation Effect of modification (process):  apoptosis, induced, transcription, inhibited

T472-p - CTNNB1 (human) ▲
Modsite: ICALRHLtsRHQEAE SwissProt Entrez-Gene Orthologous residues CTNNB1 (human): T472‑p, CTNNB1 (mouse): T472‑p, CTNNB1 (rat): T472‑p, CTNNB1 (rabbit): T472‑p Characterization Enzymes shown to modify site in vitro:  Type Enzyme KINASE CAMK2A (human) Downstream Regulation Effect of modification (process):  apoptosis, induced, transcription, inhibited

S552-p - CTNNB1 (human) ▲
Modsite: QDtQRRtsMGGtQQQ SwissProt Entrez-Gene Orthologous residues CTNNB1 (human): S552‑p, CTNNB1 (mouse): S552‑p, CTNNB1 (rat): S552‑p, CTNNB1 (rabbit): S552‑p Characterization Enzymes shown to modify site in vitro:  Type Enzyme KINASE CAMK2A (human) Downstream Regulation Effect of modification (process):  apoptosis, induced, transcription, inhibited